Soyoung is a visionary leader who aims to keep people healthy through transformative longevity technologies and healthcare infrastructures.

During 15+ years of extensive experience in entrepreneurship and investment, Soyoung has invested in 20+ emerging life sciences companies and contributed to the exits of 3 companies through acquisitions, including Nellix Endovascular (acquired by Endologix), Hotspur Technologies (acquired by Teleflex) and GBT (sold to Pfizer).

She also serves as a mentor and speaker for numerous reputable global accelerators and life science conferences, sharing her wealth of knowledge and experience with the next generation of leaders.

Soyoung holds an MBA from the Fuqua School of Business at Duke University, with a focus on Health Sector Management and Strategy.